These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 30884858)

  • 1. Ion Channels: New Actors Playing in Chemotherapeutic Resistance.
    Kischel P; Girault A; Rodat-Despoix L; Chamlali M; Radoslavova S; Abou Daya H; Lefebvre T; Foulon A; Rybarczyk P; Hague F; Dhennin-Duthille I; Gautier M; Ouadid-Ahidouch H
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30884858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion Channel Involvement in Tumor Drug Resistance.
    Altamura C; Gavazzo P; Pusch M; Desaphy JF
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRP Channels: The Neglected Culprits in Breast Cancer Chemotherapy Resistance?
    Soussi M; Hasselsweiller A; Gkika D
    Membranes (Basel); 2023 Sep; 13(9):. PubMed ID: 37755210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion channels and their role in chemo-resistance.
    Delisi DA; Saatloo MV
    Curr Top Membr; 2023; 92():125-150. PubMed ID: 38007265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ion Channels in Cancer: Are Cancer Hallmarks Oncochannelopathies?
    Prevarskaya N; Skryma R; Shuba Y
    Physiol Rev; 2018 Apr; 98(2):559-621. PubMed ID: 29412049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy.
    Arcangeli A; Crociani O; Lastraioli E; Masi A; Pillozzi S; Becchetti A
    Curr Med Chem; 2009; 16(1):66-93. PubMed ID: 19149563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms for tumour resistance to chemotherapy.
    Pan ST; Li ZL; He ZX; Qiu JX; Zhou SF
    Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):723-37. PubMed ID: 27097837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focus on Triple-Negative Breast Cancer: Potassium Channel Expression and Clinical Correlates.
    Lastraioli E
    Front Pharmacol; 2020; 11():725. PubMed ID: 32508650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emergence of drug resistance to targeted cancer therapies: Clinical evidence.
    Sarmento-Ribeiro AB; Scorilas A; Gonçalves AC; Efferth T; Trougakos IP
    Drug Resist Updat; 2019 Dec; 47():100646. PubMed ID: 31733611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer drug resistance in primary human brain tumors.
    Bredel M
    Brain Res Brain Res Rev; 2001 Apr; 35(2):161-204. PubMed ID: 11336781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
    Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
    Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: the p53 connection.
    Hasna J; Hague F; Rodat-Despoix L; Geerts D; Leroy C; Tulasne D; Ouadid-Ahidouch H; Kischel P
    Cell Death Differ; 2018 Mar; 25(4):693-707. PubMed ID: 29323264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ion channels in the regulation of apoptosis.
    Kondratskyi A; Kondratska K; Skryma R; Prevarskaya N
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2532-46. PubMed ID: 25450339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis.
    Wang X; He S; Gu Y; Wang Q; Chu X; Jin M; Xu L; Wu Q; Zhou Q; Wang B; Zhang Y; Wang H; Zheng L
    EBioMedicine; 2019 Feb; 40():251-262. PubMed ID: 30738829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological targeting of ion channels for cancer therapy: In vivo evidences.
    Leanza L; Managò A; Zoratti M; Gulbins E; Szabo I
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt B):1385-97. PubMed ID: 26658642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.